Get Premium to unlock powerful stock data
NAS:NMRD (USA)  
Nemaura Medical Inc logo

Nemaura Medical Inc

$ 2.57 0 (0%) 08:08 PM EST
P/E:
At Loss
P/B:
135.26
Market Cap:
$ 61.94M
Enterprise V:
$ 63.38M
Volume:
3.09K
Avg Vol (2M):
5.97K
Also Trade In:
Volume:
3.09K
Market Cap $:
61.94M
PE Ratio:
At Loss
Avg Vol (2-Month):
5.97K
Enterprise Value $:
63.38M
PB Ratio:
135.26
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Nemaura Medical Inc
NAICS : 339112 SIC : 5047
57 West 57th Street, New York, NY, USA, 10019
Description
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter with an app displaying glucose readings at five minute intervals for periods up to 24 hours.
Name Current Vs Industry Vs History
Cash-To-Debt 0.93
Equity-to-Asset 0.02
Debt-to-Equity 41.18
Debt-to-EBITDA -2.61
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.81
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 34.72
9-Day RSI 40.09
14-Day RSI 41.28
6-1 Month Momentum % -38.16
12-1 Month Momentum % -71.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.98
Quick Ratio 0.9
Cash Ratio 0.86
Days Inventory 1213.84
Days Sales Outstanding 156.79
Days Payable 175.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.1
Name Current Vs Industry Vs History
Gross Margin % 31.55
Operating Margin % -1502.18
Net Margin % -2755.36
ROE % -313.04
ROA % -45.77
ROIC % -47
ROC (Joel Greenblatt) % -493.55
ROCE % -47.96

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 122.38
PB Ratio 135.26
EV-to-EBIT -8.37
EV-to-EBITDA -8.63
EV-to-Revenue 125.76
EV-to-Forward-Revenue 37.28
EV-to-FCF -8.5
Earnings Yield (Greenblatt) % -11.95

Financials (Next Earnings Date:2022-08-16 Est.)

NMRD's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:NMRD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.504
EPS (TTM) ($) -0.59
Beta -0.84
Volatility % 42.6
14-Day RSI 41.28
14-Day ATR ($) 0.183368
20-Day SMA ($) 2.7224
12-1 Month Momentum % -71.66
52-Week Range ($) 2.15 - 10.7262
Shares Outstanding (Mil) 24.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nemaura Medical Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More